Toll Free: 1-888-928-9744
Published: May, 2015 | Pages:
23 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Avaxia Biologics, Inc. - Product Pipeline Review - 2015 Summary Global Markets Direct's, 'Avaxia Biologics, Inc. - Product Pipeline Review - 2015', provides an overview of the Avaxia Biologics, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Avaxia Biologics, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Avaxia Biologics, Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Avaxia Biologics, Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Avaxia Biologics, Inc.'s pipeline products Reason to Buy - Evaluate Avaxia Biologics, Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Avaxia Biologics, Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Avaxia Biologics, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Avaxia Biologics, Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Avaxia Biologics, Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope - Explore the dormant and discontinued projects of Avaxia Biologics, Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 3 Avaxia Biologics, Inc. Snapshot 4 Avaxia Biologics, Inc. Overview 4 Key Information 4 Key Facts 4 Avaxia Biologics, Inc. - Research and Development Overview 5 Key Therapeutic Areas 5 Avaxia Biologics, Inc. - Pipeline Review 7 Pipeline Products by Stage of Development 7 Pipeline Products - Monotherapy 8 Avaxia Biologics, Inc. - Pipeline Products Glance 9 Avaxia Biologics, Inc. - Clinical Stage Pipeline Products 9 Phase I Products/Combination Treatment Modalities 9 Avaxia Biologics, Inc. - Early Stage Pipeline Products 10 Preclinical Products/Combination Treatment Modalities 10 Discovery Products/Combination Treatment Modalities 11 Avaxia Biologics, Inc. - Drug Profiles 12 AVX-470 12 Product Description 12 Mechanism of Action 12 R&D Progress 12 AVX-176 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 Antibody for Obesity and Type II Diabetes 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 Avaxia Biologics, Inc. - Pipeline Analysis 15 Avaxia Biologics, Inc. - Pipeline Products by Target 15 Avaxia Biologics, Inc. - Pipeline Products by Route of Administration 16 Avaxia Biologics, Inc. - Pipeline Products by Molecule Type 17 Avaxia Biologics, Inc. - Pipeline Products by Mechanism of Action 18 Avaxia Biologics, Inc. - Recent Pipeline Updates 19 Avaxia Biologics, Inc. - Locations And Subsidiaries 21 Head Office 21 Appendix 22 Methodology 22 Coverage 22 Secondary Research 22 Primary Research 22 Expert Panel Validation 22 Contact Us 22 Disclaimer 23
List of Tables
Avaxia Biologics, Inc., Key Information 4 Avaxia Biologics, Inc., Key Facts 4 Avaxia Biologics, Inc. - Pipeline by Indication, 2015 6 Avaxia Biologics, Inc. - Pipeline by Stage of Development, 2015 7 Avaxia Biologics, Inc. - Monotherapy Products in Pipeline, 2015 8 Avaxia Biologics, Inc. - Phase I, 2015 9 Avaxia Biologics, Inc. - Preclinical, 2015 10 Avaxia Biologics, Inc. - Discovery, 2015 11 Avaxia Biologics, Inc. - Pipeline by Target, 2015 15 Avaxia Biologics, Inc. - Pipeline by Route of Administration, 2015 16 Avaxia Biologics, Inc. - Pipeline by Molecule Type, 2015 17 Avaxia Biologics, Inc. - Pipeline Products by Mechanism of Action, 2015 18 Avaxia Biologics, Inc. - Recent Pipeline Updates, 2015 19
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.